Last reviewed · How we verify

NCT03783806: PCHOAI

Postural Control in Degenerative and Inflammatory Diseases of the Hip

Status unknown Last updated 24 December 2018
What this trial tests

trial testing Posturography measurements in Hip Osteoarthritis in 90 participants. Status unknown.

Timeline
1 January 2015
Primary endpoint
18 December 2018
18 December 2018

Quick facts

Lead sponsorSzeged University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment90
Start date1 January 2015
Primary completion18 December 2018
Estimated completion18 December 2018
Sites1 location across Hungary

Drugs / interventions tested

Conditions studied

Sponsor

Szeged University

Who can join

Eligibility, any sex, with Hip Osteoarthritis or Hip Arthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with primary hip osteoarthritis (OA group) and patients with inflammatory hip disease (RA group) and healthy subjects (control group) are enrolled in the study. The aim of our study is to determine the postural control in patients suffering from OA and RA of the hip joint during different conditions, i.e., on both stable and compliant surfaces with opened or closed eyes to determine the possible differences between these two diseases in this respect.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

Other Szeged University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03783806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing